How Neuropeptides Drive Severe Itching in Bullous Pemphigoid
Substance P, neurokinin 1 receptor, and IL-31 signaling are key drivers of itch in bullous pemphigoid, offering potential therapeutic targets.
Quick Facts
What This Study Found
Itch severity in bullous pemphigoid correlates with eosinophils, substance P, neurokinin 1 receptor, IL-31 signaling, IL-13, periostin, and basophils, while mast cells and TRPV1 were not significantly correlated.
Key Numbers
24 BP patients; 6 controls; itch correlated with SP, NK1R, IL-31RA, eosinophils, IL-13, periostin, basophils
How They Did This
Immunofluorescence staining of skin lesions from 24 BP patients and 6 healthy controls, with correlation analysis between mediator expression and itch severity.
Why This Research Matters
Identifying specific neuropeptide and immune pathways driving itch in BP could lead to targeted therapies like NK1R antagonists or anti-IL-31 drugs, replacing broad immunosuppression.
The Bigger Picture
Understanding neuropeptide-driven itch mechanisms in autoimmune blistering diseases opens the door to targeted anti-itch treatments that could benefit patients with BP and related conditions.
What This Study Doesn't Tell Us
Small sample size (30 total). Cross-sectional design cannot establish causation. Limited to immunofluorescence analysis without functional assays.
Questions This Raises
- ?Would NK1R antagonists effectively reduce itch in BP patients?
- ?Do anti-IL-31 therapies like nemolizumab work for BP-associated itch?
- ?Why are mast cells not correlated with itch severity despite their established role in other pruritic conditions?
Trust & Context
- Key Stat:
- 24 patients BP patients whose skin lesions were analyzed for itch mediator expression
- Evidence Grade:
- Small observational study providing correlational evidence. Immunofluorescence-only analysis without functional validation limits conclusions.
- Study Age:
- Published in 2020, the findings remain relevant as targeted anti-itch therapies continue to develop.
- Original Title:
- Pathophysiologic mechanisms of itch in bullous pemphigoid.
- Published In:
- Journal of the American Academy of Dermatology, 83(1), 53-62 (2020)
- Authors:
- Hashimoto, Takashi, Kursewicz, Christina Dorothy, Fayne, Rachel Alison, Nanda, Sonali, Shah, Serena Maya, Nattkemper, Leigh, Yokozeki, Hiroo, Yosipovitch, Gil
- Database ID:
- RPEP-04844
Evidence Hierarchy
Frequently Asked Questions
What causes the severe itching in bullous pemphigoid?
This study found that multiple neuropeptide and immune signals drive BP itch, including substance P, neurokinin 1 receptor, IL-31 signaling, and eosinophils. The itch appears to be mediated through both nervous system and immune pathways.
Are there targeted treatments for BP itch?
The findings suggest substance P blockers (NK1R antagonists) and anti-IL-31 therapies could target BP itch specifically, though clinical trials are needed to confirm this.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-04844APA
Hashimoto, Takashi; Kursewicz, Christina Dorothy; Fayne, Rachel Alison; Nanda, Sonali; Shah, Serena Maya; Nattkemper, Leigh; Yokozeki, Hiroo; Yosipovitch, Gil. (2020). Pathophysiologic mechanisms of itch in bullous pemphigoid.. Journal of the American Academy of Dermatology, 83(1), 53-62. https://doi.org/10.1016/j.jaad.2019.07.060
MLA
Hashimoto, Takashi, et al. "Pathophysiologic mechanisms of itch in bullous pemphigoid.." Journal of the American Academy of Dermatology, 2020. https://doi.org/10.1016/j.jaad.2019.07.060
RethinkPeptides
RethinkPeptides Research Database. "Pathophysiologic mechanisms of itch in bullous pemphigoid." RPEP-04844. Retrieved from https://rethinkpeptides.com/research/hashimoto-2020-pathophysiologic-mechanisms-of-itch
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.